Data Foundry

Drug recalls 2026

Lidocaine Ointment USP — Class II drug recall D-0013-2027

Ongoing recall by Preferred Pharmaceuticals, Inc., reported 2026-10-14, distributed nationwide. Failed Content Uniformity Specifications

Recall numberD-0013-2027
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmPreferred Pharmaceuticals, Inc., Anaheim, CA, United States
Recall initiated2026-09-28
Classified2026-10-06
Reported by FDA2026-10-14
DistributedNationwide (US)
NDC68788-7865-05
Lot numbersD0825D, D3025M, E0925T, F1925G
Expiration dates2027-04-30

Product

Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05

Reason for recall

Failed Content Uniformity Specifications

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0013-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-21. Not affiliated with or endorsed by FDA. Not medical or legal advice.